Oxidative stress-induced posttranslational modification of proteins as a target of functional food

Forum of Nutrition

Volumn 61, Issue , 2009, Pages 39-54

  Naito, Yuji ^a   Yoshikawa, Toshikazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN;

CHEMISTRY; FOOD; HUMAN; METABOLISM; METHODOLOGY; OXIDATIVE STRESS; PROTEIN PROCESSING; PROTEOMICS; REVIEW;

FOOD; HUMANS; OXIDATIVE STRESS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS; PROTEOMICS;

EID: 67650240130     PISSN: 16600347     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000212737     Document Type: Article

References (65)

1. Yoshikawa T, Naito Y: What is oxidative stress? JMAJ 2002;45:271-276.
2. Rhee SG: Cell signaling. H2O2, a necessary evil for cell signaling. Science 2006;312:1882-1883.
3. Kuster GM, Siwik DA, Pimentel DR, et al: Role of reversible, thioredoxin-sensitive oxidative protein modifications in cardiac myocytes. Antioxid Redox Signal 2006;8:2153-2159.
4. Eaton P, Byers HL, Leeds N, et al: Detection, quanti-tation, purification, and identification of cardiac proteins S-thiolated during ischemia and reperfu-sion. J Biol Chem 2002;277:9806-9811.
5. Ishii T, Uchida K: Induction of reversible cysteine-targeted protein oxidation by an endogenous elec-trophile 15-deoxy-delta12,14-prostaglandin J2. Chem Res Toxicol 2004;17:1313-1322.
6. Cloos PA, Christgau S: Post-translational modifications of proteins: implications for aging, antigen recognition, and autoimmunity. Biogerontology 2004;5:139-158.
7. Miyake H, Kadoya A, Ohyashiki T: Increase in molecular rigidity of the protein conformation of brain Na+-K+-ATPase by modification with 4-hydroxy-2-nonenal. Biol Pharm Bull 2003;26: 1652-1656.
8. Mark RJ, Pang Z, Geddes J W, et al: Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J Neurosci 1997;17:1046-1054.
9. Bennaars-Eiden A, Higgins L, Hertzel AV, et al: Covalent modification of epithelial fatty acid-binding protein by 4-hydroxynonenal in vitro and in vivo. Evidence for a role in antioxidant biology. J Biol Chem 2002;277:50693-50702.
10. Grimsrud PA, Picklo MJ Sr, Griffin TJ, et al: Carbonylation of adipose proteins in obesity and insulin resistance: identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal. Mol Cell Proteomics 2007;6:624- 637.
11. Yang JH, Yang ES, Park JW: Inactivation of NADP+-dependent isocitrate dehydrogenase by lipid peroxi-dation products. Free Radic Res 2004;38:241-249.
12. Cassidy PB, Edes K, Nelson CC, et al: Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles. Carcinogenesis 2006;27:2538- 2549.
13. Fang J, Holmgren A: Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo. J Am Chem Soc 2006;128:1879- 1885.
14. Park YS, Misonou Y, Fujiwara N, et al: Induction of thioredoxin reductase as an adaptive response to acrolein in human umbilical vein endothelial cells. Biochem Biophys Res Commun 2005;327:1058- 1065.
15. Park YS, Koh YH, Takahashi M, et al: Identification of the binding site of methylglyoxal on glutathione peroxidase: methylglyoxal inhibits glutathione per-oxidase activity via binding to glutathione binding sites Arg 184 and 185. Free Radic Res 2003;37:205- 211.
16. Carbone DL, Doorn JA, Kiebler Z, et al: Modification of heat shock protein 90 by 4-hydroxynonenal in a rat model of chronic alcoholic liver disease. J Pharmacol Exp Ther 2005;315:8-15.
17. Ahsan H, Ali A, Ali R: Oxygen free radicals and systemic autoimmunity. Clin Exp Immunol 2003;131: 398-404.
18. Kovacic P, Jacintho JD: Systemic lupus erythemato-sus and other autoimmune diseases from endogenous and exogenous agents: unifying theme of oxidative stress. Mini Rev Med Chem 2003;3:568- 575.
19. Toyoda K, Nagae R, Akagawa M, et al: Protein-bound 4-hydroxy-2-nonenal: an endogenous triggering antigen of antI-DNA response. J Biol Chem 2007;282:25769-25778.
20. Chang MK, Binder CJ, Miller YI, et al: Apoptotic cells with oxidation-specific epitopes are immuno-genic and proinflammatory. J Exp Med 2004;200: 1359-1370.
21. Chou MY, Hartvigsen K, Hansen LF, et al: Oxidation-specific epitopes are important targets of innate immunity. J Intern Med 2008;263:479-488.
22. Trigwell SM, Radford PM, Page SR et al: Islet glutamic acid decarboxylase modified by reactive oxygen species is recognized by antibodies from patients with type 1 diabetes mellitus. Clin Exp Immunol 2001;126:242-249.
23. Ishii T, Sakurai T, Usami H, et al: Oxidative modification of proteasome: identification of an oxidation-sensitive subunit in 26 S proteasome. Biochemistry 2005;44:13893-13901.
24. Saitoh T, Fujita N, Jang MH et al: Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 2008;456:264- 268.
25. Uchida K: Protein-bound 4-hydroxy-2-nonenal as a marker of oxidative stres. J Clin Biochem Nutr 2005;36:1-10.
26. Toyokuni S, Miyake N, Hiai H, et al: The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct. FEBS Lett 1995;359:189-191.
27. Toyokuni S, Uchida K, Okamoto K, et al: Formation of 4-hydroxy-2-nonenal- modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc Natl Acad Sci USA 1994;91:2616-2620.
28. Ihara Y, Toyokuni S, Uchida K, et al: Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes 1999;48:927-932.
29. Yamagami K, Yamamoto Y, Kume M, et al: Formation of 8-hydroxy-2′- deoxyguanosine and 4-hydroxy-2-nonenal-modified proteins in rat liver after ischemia-reperfusion: distinct localization of the two oxidatively modified products. Antioxid Redox Signal 2000;2:127-136.
30. Hartley DP, Kroll DJ, Petersen DR: Prooxidant-initiated lipid peroxidation in isolated rat hepato-cytes: detection of 4-hydroxynonenal- and malon dialdehyde-protein adducts. Chem Res Toxicol 1997;10:895-905.
31. Blasig IE, Grune T, Schonheit K, et al: 4-Hydroxynonenal, a novel indicator of lipid peroxidation for reperfusion injury of the myocardium. Am J Physiol 1995;269:H14-H22.
32. Eschwege P, Paradis V, Conti M, et al: In situ detection of lipid peroxidation by-products as markers of renal ischemia injuries in rat kidneys. J Urol 1999; 162:553-557.
33. Nair J, Gansauge F, Beger H, et al: Increased etheno-DNA adducts in affected tissues of patients suffering from Crohn's disease, ulcerative colitis, and chronic pancreatitis. Antioxid Redox Signal 2006;8: 1003-1010.
34. Kageyama F, Kobayashi Y, Kawasaki T, et al: Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C. Am J Gastroenterol 2000;95: 1041-1050.
35. Serviddio G, Bellanti F, Tamborra R, et al: Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury. Gut 2008;57:957-965.
36. Uchida K, Toyokuni S, Nishikawa K, et al: Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis. Biochemistry 1994;33:12487-12494.
37. Reed T, Perluigi M, Sultana R, et al: Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease. Neurobiol Dis 2008;30:107-120.
38. Selley ML: (E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease. Free Radic Biol Med 1998;25:169-174.
39. Perluigi M, Fai Poon H, Hensley K, et al: Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice-a model of familial amyotrophic lateral sclerosis. Free Radic Biol Med 2005;38:960-968.
40. Aoi W, Naito Y, Sakuma K, et al: Astaxanthin limits exercise-induced skeletal and cardiac muscle damage in mice. Antioxid Redox Signal 2003;5:139- 144.
41. Manabe E, Handa O, Naito Y, et al: Astaxanthin protects mesangial cells from hyperglycemia-induced oxidative signaling. J Cell Biochem 2008; 103:1925-1937.
42. Naito Y, Uchiyama K, Aoi W, et al: Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/db mice. Biofactors (Oxford) 2004; 20:49-59.
43. Kato Y, Mori Y, Makino Y, et al: Formation of Nepsilon-(hexanonyl)lysine in protein exposed to lipid hydroperoxide. A plausible marker for lipid hydroperoxide-derived protein modification. J Biol Chem 1999;274:20406-20414.
44. Kato Y, Miyake Y, Yamamoto K, et al: Preparation of a monoclonal antibody to N(epsilon)-(Hexanonyl) lysine: application to the evaluation of protective effects of flavonoid supplementation against exercise-induced oxidative stress in rat skeletal muscle. Biochem Biophys Res Commun 2000;274: 389-393.
45. Fukuchi Y, Miura Y, Nabeno Y, et al: Immuno-histochemical detection of oxidative stress biomark-ers, dityrosine and N(epsilon)-(hexanoyl)lysine, and C-reactive protein in rabbit atherosclerotic lesions. J Atheroscler Thromb 2008;15:185-192.
46. Osakabe N, Yasuda A, Natsume M, et al: Rosmarinic acid, a major polyphenolic component of Perilla frutescens, reduces lipopolysaccharide (LPS)-induced liver injury in d-galactosamine (D-GalN)-sensitized mice. Free Radic Biol Med 2002;33: 798-806.
47. Yasuda A, Takano H, Osakabe N, et al: Cacao liquor proanthocyanidins inhibit lung injury induced by diesel exhaust particles. Int J Immunopathol Pharmacol 2008;21:279-288.
48. Aoi W, Naito Y, Takanami Y, et al: Astaxanthin improves muscle lipid metabolism in exercise via inhibitory effect of oxidative CPT I modification. Biochem Biophys Res Commun 2008;366:892-897.
49. Naito Y, Takano H, Yoshikawa T: Oxidative stress-related molecules as a therapeutic target for inflammatory and allergic diseases. Curr Drug Targets 2005;4:511-515.
50. Winterbourn CC, Kettle AJ: Biomarkers of myelo-peroxidase-derived hypochlorous acid. Free Radic Biol Med 2000;29:403-409.
51. Gujral JS, Hinson JA, Jaeschke H: Chlorotyrosine protein adducts are reliable biomarkers of neutro-phil-induced cytotoxicity in vivo. Comp Hepatol 2004;3(suppl 1):S48.
52. Ryu JK, Tran KC, McLarnon JG: Depletion of neu-trophils reduces neuronal degeneration and inflammatory responses induced by quinolinic acid in vivo. Glia 2007;55:439-451.
53. Heinecke JW: The HDL proteome: a marker - and perhaps mediator - of coronary artery disease. J Lipid Res 2008; Epub ahead of print.
54. Shao B, Oda MN, Bergt C, et al: Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I. J Biol Chem 2006;281:9001-9004.
55. Kunitomo M, Yamaguchi Y, Kagota S, et al: Beneficial effect of coenzyme Q10 on increased oxi-dative and nitrative stress and inflammation and individual metabolic components developing in a rat model of metabolic syndrome. J Pharmacol Sci 2008;107:128-137.
56. Yamaguchi Y, Yamada K, Yoshikawa N, et al: Corosolic acid prevents oxidative stress, inflammation and hypertension in SHR/NDmcr-cp rats, a model of metabolic syndrome. Life Sci 2006;79: 2474-2479.
57. Bayir H, Kagan VE, Clark RS, et al: Neuronal NOS-mediated nitration and inactivation of manganese superoxide dismutase in brain after experimental and human brain injury. J Neurochem 2007;101:168- 181.
58. Tangpong J, Cole MP, Sultana R, et al: Adriamycin-mediated nitration of manganese superoxide dis-mutase in the central nervous system: insight into the mechanism of chemobrain. J Neurochem 2007; 100:191-201.
59. Anantharaman M, Tangpong J, Keller JN, et al: Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of Alzheimer's disease. Am J Pathol 2006;168:1608-1618.
60. MacMillan-Crow LA, Crow J P, Thompson JA: Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry 1998; 37:1613-1622.
61. Yamakura F, Taka H, Fujimura T, et al: Inactivation of human manganese-superoxide dismutase by per-oxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J Biol Chem 1998;273:14085- 14089.
62. Ye o WS, Lee SJ, Lee JR, et al: Nitrosative protein tyrosine modifications: biochemistry and functional significance. BMB Rep 2008;41:194-203.
63. Kruger AL, Peterson SJ, Schwartzman ML, et al: Up-regulation of heme oxygenase provides vascular protection in an animal model of diabetes through its antioxidant and antiapoptotic effects. J Pharmacol Exp Ther 2006;319:1144-1152.
64. Musso G, Gambino R, De Michieli F, et al: Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin A intake. Am J Clin Nutr 2007;86:661-671.
65. Devaraj S, Leonard S, Traber MG, et al: Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome. Free Radic Biol Med 2008; 44: 1203-1208.